Precision Medicine

While 177Lu-PSMA-617 has improved survival, many patients eventually see their cancer progress as the disease develops resistance to beta-particle radiation. This clinical hurdle has forced researchers to look beyond standard therapies toward the high-energy potential of alpha-emitting isotopes.

Leptomeningeal disease represents a particular diagnostic challenge where cancer spreads to the protective membranes and fluid surrounding the brain. This condition often presents a clinical puzzle, as the traditional tools used to visualize the central nervous system frequently struggle to provide

The 12 mg dose of retatrutide helped patients lose more than one-fifth of their body weight, setting a new benchmark for pharmacological obesity interventions. This milestone represents a paradigm shift in the treatment of chronic metabolic conditions, moving beyond simple blood sugar regulation

Researchers analyzing the DNA of UK Biobank participants found 60 independent genetic variants associated with liver triglyceride levels. This monumental effort, which utilized magnetic resonance imaging data from a cohort of 71,488 individuals of European descent, has fundamentally altered the

The development of B-SYNC is an evolution of the 2021 E-SYNC model, moving from a rare mutant protein trigger to a more universal brain protein to help a broader range of patients. In the current landscape of pediatric medicine, few diagnoses carry as much weight as diffuse midline glioma, an

The Light Gradient Boosting Machine emerged as the most effective tool for calculating the probability of plaque rupture based on systemic biological indicators. This innovative approach addresses the critical challenge of identifying vulnerable carotid plaques before they lead to catastrophic